The final 5% doesn't issue until approval, which will be a rocket for this stock. Probably post-Nuvaring too.
This pill is a native estrogen derived from plants and has a large testing pool and 20 year's research. If people don't think the 1st part isn't money in the bank, I've got no idea what it will take to convince them.
Congratulations Mithra, page-10
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.03 |
Change
-0.190(4.50%) |
Mkt cap ! $342.8M | |||
| Open | High | Low | Value | Volume |
| $4.10 | $4.22 | $4.02 | $1.235M | 303.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $4.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.04 | 164 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |